Table 2.

Hospital visits, admissions and length of stay during 6-month episodes before and after rifaximin-α initiation.

	6 months prior to rifaximin-α initiation	6 months after rifaximin-α initiation	p value
HE-related admissions on the general ward per patient in 6 months, mean (SD)	0.86 (0.81)	0.41 (0.80)	<0.001
HE-related hospital bed days on the general ward per admission in 6 months, mean (SD)	8.85 (11.20)	3.79 (9.37)	<0.001
HE-related admissions on the intensive care unit per patient in 6 months, mean (SD)	0.09 (0.29)	0.06 (0.23)	0.253
HE-related hospital bed days on the intensive care unit per admission in 6 months, mean (SD)	0.43 (1.64)	0.57 (3.17)	0.661
Liver-related hospital bed days in 6 months, mean (SD)	17.18 (18.68)	10.15 (14.81)	0.021
Nonliver-related hospital bed days in 6 months, mean (SD)	0.55 (2.27)	0.40 (1.44)	0.585
A&E department visits per patient in 6 months, mean (SD)	0.66 (1.06)	0.51 (1.11)	0.220
Outpatient clinic visits per patient in 6 months, mean (SD)	2.94 (2.64)	3.30 (3.21)	0.240

A&E, accident and emergency; HE, hepatic encephalopathy; SD, standard deviation.